134 related articles for article (PubMed ID: 6970745)
21. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
Janatova J
Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
[No Abstract] [Full Text] [Related]
22. Anaphylatoxin levels in human vitreous humor.
Mondino BJ; Sidikaro Y; Sumner H
Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
[TBL] [Abstract][Full Text] [Related]
23. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
24. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
Terui T; Takematsu H; Kato T; Ohkohchi K; Tagami H
Tohoku J Exp Med; 1987 Feb; 151(2):245-52. PubMed ID: 3495048
[TBL] [Abstract][Full Text] [Related]
25. Purification and partial characterization of human and porcine C3a anaphylatoxin.
Hugli TE; Vallota EH; Müller-Eberhard HJ
J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
[TBL] [Abstract][Full Text] [Related]
26. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
Takematsu H; Ohkohchi K; Tagami H
Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
[TBL] [Abstract][Full Text] [Related]
27. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
Ohkohchi K; Takematsu H; Tagami H
Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
[TBL] [Abstract][Full Text] [Related]
28. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
29. Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a).
Jacobs JW; Rubin JS; Hugli TE; Bogardt RA; Mariz IK; Daniels JS; Daughaday WH; Bradshaw RA
Biochemistry; 1978 Nov; 17(23):5031-8. PubMed ID: 309768
[TBL] [Abstract][Full Text] [Related]
30. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
Nagata S; Glovsky MM
J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
[TBL] [Abstract][Full Text] [Related]
31. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.
Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
Clin Exp Immunol; 1990 May; 80(2):167-70. PubMed ID: 2357842
[TBL] [Abstract][Full Text] [Related]
32. Purification and functional assessment of C3a, C4a and C5a of the common carp (Cyprinus carpio) complement.
Kato Y; Nakao M; Shimizu M; Wariishi H; Yano T
Dev Comp Immunol; 2004 Jul; 28(9):901-10. PubMed ID: 15183031
[TBL] [Abstract][Full Text] [Related]
33. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
[TBL] [Abstract][Full Text] [Related]
34. Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.
Ohkohchi K; Takematsu H; Tagami H
J Invest Dermatol; 1986 Jul; 87(1):65-7. PubMed ID: 3487596
[TBL] [Abstract][Full Text] [Related]
35. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
[TBL] [Abstract][Full Text] [Related]
36. Anaphylatoxins in preterm and term labor.
Soto E; Romero R; Richani K; Espinoza J; Nien JK; Chaiworapongsa T; Santolaya-Forgas J; Edwin SS; Mazor M
J Perinat Med; 2005; 33(4):306-13. PubMed ID: 16207115
[TBL] [Abstract][Full Text] [Related]
37. Anaphylatoxin formation in extracorporeal circuits.
Chenoweth DE
Complement; 1986; 3(3):152-65. PubMed ID: 3492330
[TBL] [Abstract][Full Text] [Related]
38. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
Miadonna A; Leggieri E; Tedeschi A; Cottini M; Invernizzi F; Froldi M; Zanussi C
Int Arch Allergy Appl Immunol; 1985; 76(2):120-5. PubMed ID: 3967939
[TBL] [Abstract][Full Text] [Related]
39. Evidence that the receptor for C4a is distinct from the C3a receptor.
Ames RS; Tornetta MA; Foley JJ; Hugli TE; Sarau HM
Immunopharmacology; 1997 Dec; 38(1-2):87-92. PubMed ID: 9476119
[TBL] [Abstract][Full Text] [Related]
40. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
Hoeprich PD; Hugli TE
Biochemistry; 1986 Apr; 25(8):1945-50. PubMed ID: 3486674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]